APOE and atherosclerosis: Pre-clinical studies using statins, which inhibit the HMG-CoA reductase to block cholesterol de novo synthesis, in ApoE-deficient mice revealed a marked regression of atherosclerosis through a CCR7-dependent emigration of foam cells from plaques (Feig et al., 2011) supporting this hypothesis.